Due to the number of requests received, all of the articles, newsletters, etc. related to Professional Practice Standards and the "lack of authority" of the United States Pharmacopeia (USP) General Chapters (<795>, <797>, <800>) have been compiled into one document which can be downloaded FREE at the Compounding Today website. Go to:
http://CompoundingToday.com/Compliance/USP Lack of Authority to Establish Professional Practice Standards.pdf
Since the responsibility for pharmacy laws, regulations, and practice standards belong to the individual state boards of pharmacy, these materials can be used to support the transition from relying on USP's chapters to state-developed regulations and standards.
It appears the state boards use of the USP materials has fallen into 3 categories:
- Not use the USP professional practice chapters.
- Rewrite the USP professional practice chapters according to the uniqueness of an individual state.
- Incorporate by reference the USP professional practice chapters.
Utilizing numerous materials that are available, individual state boards can develop their own professional practice standards for their states that are science-based and reasonable. Not all content or sections of published standards may be reasonable in all states. It is up to the individual state to determine what it is or is not appropriate for their state. The individual state can reference numerous documents and incorporate their respective state nuances. There are many individual considerations various states can make so that quality professional practice standards are more workable.
It is important that pharmacists from ALL practice settings have input with their individual boards and provide information, documentation, and support in whatever way is needed. It is important for all to be involved in setting standards to enhance quality compounding and ensure patient access to individualized medications.
Note: Next week we will begin a new series on the Compliance Policy Guidelines published by the FDA related to pharmacy compounding/practice. Due to the above announcement, it was decided to postpone beginning the FDA CPG discussions until next week.
Loyd V. Allen, Jr., PhD, RPh
Editor-in-Chief
International Journal of Pharmaceutical Compounding
Remington: The Science and Practice of Pharmacy Twenty-second edition
|